These data might lead to a striking change in our view of the role that mTOR inhibition should have in immunosuppressive therapy for allogeneic transplant recipients. You have full access to this ...

The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to ...

A groundbreaking review highlights significant advancements in the understanding and treatment of cerebral vascular ...

The researchers used the mTOR inhibitor sirolimus, which was first approved in 1999 to prevent organ rejection after kidney transplants. It had already shown promise in preclinical models of ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions ...

Cerebral vascular malformations (CVMs), including cerebral arteriovenous malformations (AVMs) and cavernous malformations (CCMs), have long posed challenges due to their complex origins and severe ...